Other clinical trials in patients with non-Hodgkin's lymphoma [24] and sufferers with Superior malignancy [14] have shown also that zosuquidar did not drastically have an affect on the pharmacokinetics of doxorubicin and experienced reasonable outcomes over the pharmacokinetics of vincristine. These scientific trials approved that zosuquidar could … Read More